Free Trial

ExodusPoint Capital Management LP Sells 102,397 Shares of Privia Health Group, Inc. (NASDAQ:PRVA)

Privia Health Group logo with Medical background

ExodusPoint Capital Management LP decreased its holdings in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 87.1% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 15,181 shares of the company's stock after selling 102,397 shares during the period. ExodusPoint Capital Management LP's holdings in Privia Health Group were worth $297,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Cinctive Capital Management LP bought a new position in Privia Health Group in the 4th quarter worth about $2,723,000. Trexquant Investment LP purchased a new position in Privia Health Group in the fourth quarter worth about $1,720,000. Franklin Resources Inc. lifted its stake in shares of Privia Health Group by 0.8% in the fourth quarter. Franklin Resources Inc. now owns 1,311,166 shares of the company's stock worth $25,633,000 after buying an additional 10,926 shares in the last quarter. Alliancebernstein L.P. grew its holdings in shares of Privia Health Group by 1.4% during the fourth quarter. Alliancebernstein L.P. now owns 134,244 shares of the company's stock valued at $2,624,000 after buying an additional 1,900 shares during the last quarter. Finally, Schroder Investment Management Group grew its holdings in shares of Privia Health Group by 2.6% during the fourth quarter. Schroder Investment Management Group now owns 210,833 shares of the company's stock valued at $4,105,000 after buying an additional 5,326 shares during the last quarter. 94.48% of the stock is currently owned by hedge funds and other institutional investors.

Privia Health Group Trading Down 0.8 %

NASDAQ PRVA traded down $0.19 on Friday, hitting $23.68. 845,501 shares of the company traded hands, compared to its average volume of 782,638. The business's 50 day moving average price is $23.82 and its 200-day moving average price is $21.67. Privia Health Group, Inc. has a 52-week low of $15.92 and a 52-week high of $26.04. The company has a market capitalization of $2.87 billion, a price-to-earnings ratio of 236.82, a P/E/G ratio of 3.47 and a beta of 0.88.

Analyst Ratings Changes

Several equities analysts recently issued reports on PRVA shares. Robert W. Baird upped their price objective on Privia Health Group from $24.00 to $26.00 and gave the company an "outperform" rating in a research report on Tuesday. Needham & Company LLC reaffirmed a "buy" rating and set a $30.00 price target on shares of Privia Health Group in a report on Thursday, April 10th. Truist Financial lifted their price objective on Privia Health Group from $27.00 to $28.00 and gave the stock a "buy" rating in a report on Thursday, April 10th. JMP Securities set a $29.00 target price on shares of Privia Health Group in a research note on Friday, February 28th. Finally, Canaccord Genuity Group lifted their price target on shares of Privia Health Group from $29.00 to $30.00 and gave the stock a "buy" rating in a research note on Friday, February 28th. One research analyst has rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat, Privia Health Group currently has a consensus rating of "Buy" and an average price target of $27.00.

Check Out Our Latest Report on Privia Health Group

Insider Transactions at Privia Health Group

In related news, CFO David Mountcastle sold 5,630 shares of the stock in a transaction that occurred on Wednesday, April 2nd. The shares were sold at an average price of $22.38, for a total value of $125,999.40. Following the completion of the sale, the chief financial officer now directly owns 179,676 shares of the company's stock, valued at approximately $4,021,148.88. This represents a 3.04 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 14.20% of the company's stock.

Privia Health Group Profile

(Free Report)

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.

Read More

Institutional Ownership by Quarter for Privia Health Group (NASDAQ:PRVA)

Should You Invest $1,000 in Privia Health Group Right Now?

Before you consider Privia Health Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Privia Health Group wasn't on the list.

While Privia Health Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Sectors With Massive Momentum You Can’t Afford to Miss
Palantir’s Big Moves: Profit-Taking, Price Targets & AI Potential
Buy Early: 3 Tech Trends With Millionaire-Making Potential

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines